Evaluating effectiveness of syringe exchange programmes: Current issues and future prospects

Social Science and Medicine

Volumn 51, Issue 12, 2000, Pages 1771-1782

  Bastos, F I ^a   Strathdee, S A ^b  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Blood borne infections; Ecological studies; Epidemiology; HIV; Injecting drug users; Syringe exchange programmes

Indexed keywords

ARTICLE; DISEASE TRANSMISSION; DRUG ABUSE; HEALTH BEHAVIOR; HEALTH CARE POLICY; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFECTION; INJECTION; SYRINGE;

BLOOD-BORNE PATHOGENS; BRAZIL; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEALTH BEHAVIOR; HEALTH POLICY; HIV INFECTIONS; HUMANS; NEEDLE-EXCHANGE PROGRAMS; NEPAL; SUBSTANCE ABUSE, INTRAVENOUS; UNITED STATES;

EID: 0034672781     PISSN: 02779536     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0277-9536(00)00109-X     Document Type: Article

References (94)

1. Heterosexual transmission of HIV: The role of other sexually infections and behaviour in its epidemiological prevention and control
2. Factors associated with frequent needle exchange program attendance in injection drug users in Vancouver, Canada
3. Overview: Policies and interventions to stem HIV-1 epidemics associated with injecting drug use
4. Cities responding to HIV-1 epidemics among injecting drug users
5. Drug abuse and the spread of HIV/AIDS in South America and the Caribbean
6. Double infection with HIV and malaria among Brazilian IDUs: A new challenge?
7. Measuring HIV-1 incidence in Northern Thailand: Prospective cohort results and estimates based on early diagnostic tests
8. Estimation of current human immunodeficiency virus incidence rates from a cross-sectional survey using early diagnostic tests
9. The AIDS epidemic in India: A new method for estimating current human immunodeficiency virus (HIV) incidence rates
10. Human immunodeficiency virus transmission and the role of other sexually transmitted diseases: Measures of association and study design
11. Mathematical models of disease transmission: A precious tool for the study of sexually transmitted diseases
12. High rates of HIV infection among injection drug users participating in needle exchange programs in Montreal: Results of a cohort study
13. Assessing harms reduction strategies: The dilemma of observational studies
14. Drs. Bruneau, Lamothe and Franco reply
15. HIV and infections of similar transmission patterns in a drug injectors community of Santos, Brazil
16. Arrests and incarceration of injection drug users for syringe possession in Massachusetts; implications for HIV prevention
17. The risk of infection with HIV and hepatitis B in individuals who inject steroids in England and Wales
18. Fifteen years of research on preventing HIV infection among injecting drug users: What we have learned, what we have not learned, what we have done, what we have not done
19. Maintaining low HIV seroprevalence in populations of injection drug users
20. HIV incidence among injecting drug users in New York City syringe-exchange programmes
21. Use of a new 'less-sensitive enzyme immunoassay' testing strategy to identify recently infected persons in a Brazilian prison: Estimation of incidence and epidemiological tracing
22. Bringing context back into epidemiology: Variables and fallacies in multilevel analysis
23. AIDS behind bars: Preventing HIV among incarcerated drug injectors
24. Measuring harm reduction: The effects of needle and syringe exchange programs and methadone maintenance on the ecology of HIV
25. Sociometric risk networks and risk for HIV infection
26. The legal environment impeding access to sterile syringes and needles: The conflict between law enforcement and public health
27. Drug use-contexts and HIV-consequences: The effect of drug policy on patterns of everyday drug use in Rotterdam and the Bronx
28. Reduced risk of Hepatitis B and Hepatitis C among injection drug users in the Tacoma Syringe Exchange Program
29. Syringe exchange and risk of infection with hepatitis B and C viruses
30. Who uses needle exchange? A study of injection drug users in treatment in San Francisco, 1989-1990
31. Direct and indirect effects in vaccine efficacy and effectiveness
32. Study designs for dependent happenings
33. Causal inference in infectious diseases
34. A qualitative investigation into a HIV outbreak among injection drug users in Vancouver, British Columbia
35. Syringe use and reuse: Effects of syringe exchange programs in four cities
36. Hepatitis in used syringes: The limits of sensitivity of techniques to detect hepatitis B virus (HBV) DNA, hepatitis C virus (HCV) RNA, and antibodies to HBV core and HCV antigens
37. Detection by polymerase chain reaction of human immunodeficiency virus type 1 proviral DNA sequences in needles of injecting drug users
38. Effectiveness of needle-exchange programmes for prevention of HIV infection
39. New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes
40. Syringe exchange not associated with social network formation: Results from Baltimore
41. A method for evaluating needle exchange programmes
42. HIV incidence among needle exchange participants: Estimates from syringe tracking and testing data
43. Evaluation of syringe-exchange for HIV prevention among injecting drug users in rural and urban areas of Wales
44. The prevalence of additional injection-related HIV risk behaviours among injection drug users
45. Modelling the spread of HIV in social networks of injecting drug users
46. New sharing partners encounter places among needle exchange attenders
47. People and places: Behavioural settings and personal network characteristics as correlates of needle sharing
48. Modeling incidence rate to ratio and rate difference: Additivity or multiplicativity of HIV parenteral and sexual transmission among intravenous drug users
49. Re: 'High rates of HIV infection among injection drug users participating in needle exchange programs in Montreal: Results of a cohort study'
50. When science and politics collide
51. Invited commentary: Le mystere de Montreal
52. Dr. Lurie replies
53. An opportunity lost: HIV infections associated with lack of a national needle exchange programme in the USA
54. A sterile syringe for every drug user injection: How many injections take place annually, and how might pharmacists contribute to syringe distribution
55. The validation of statements by IDUs based on the analysis of blood traces on their used syringes
56. Epidemiology and social networks: Modeling structured diffusion
57. Sexual networks and HIV
58. Needle exchange: No help for hepatitis
59. The relevance of drug injector's social and risk networks for understanding and preventing HIV infection
60. Preventing HIV transmission in prison: A tale of medical disobedience and Swiss pragmatism
61. Syringe exchange in the United States, 1996: A national profile
62. Delining risk for HIV among injecting drug users in Hathmandu, Nepal: The impact of a harm-reduction programme
63. Enough sterile syringes to prevent HIV transmission among injecting drug users in Montreal
64. Drug injecting, rapid HIV spread, and the 'risk environment': Implications for assessment and response
65. Strict syringe laws in Rhode Island are associated with high rates of reusing syringes and HIV risks among injection drug users
66. Detection of HIV-1 nucleic acid and HIV-1 antibodies in needles and syringes used for non-intravenous injection
67. Do needle exchange programmes increase the spread of HIV among injection drug users?: An investigation of the Vancouver outbreak
68. Needle exchange use among a cohort of injecting drug users
69. Detection of HIV-1 DNA in needles/syringes, paraphernalia, and washes from shooting galleries in Miami: A preliminary laboratory report
70. HIV-1 RNA load in needles/syringes from shooting galleries in Miami: A preliminary laboratory report
71. Two steps forward, one step back: Anti-user bias in New York State's approach to needle exchange
72. AIDS and injecting drug use in the United Kingdom, 1987-1993: The policy response and the prevention of the epidemic
73. Has the United Kingdom averted an epidemic of HIV among injection drug users?
74. Can HIV epidemics among injection drug users be prevented?
75. Needle exchange attendance and health care utilization promote entry into detoxification
76. Needle exchange is not enough: Lessons from the Vancouver Injection Drug Use Study
77. The logic in ecological. I. The logic of analysis
78. Outbreak of HIV infection in a Scottish prison
79. Preventing HIV/AIDS and other sexually transmitted diseases among injecting drug users in Rio de Janeiro
80. Risk behaviours and HIV seroprevalence among IDUs in Rio de Janeiro, Brazil
81. Satellite exchange in the Baltimore Needle Exchange Program
82. Injecting risk behaviour among drug users in Amsterdam, 1986 to 1992, and its relationship to AIDS prevention programs
83. Maximum impact of HIV prevention measures targeted at injecting drug users
84. Risk reduction among intravenous drug users in Amsterdam under the influence of AIDS
85. The role of conceptual frameworks in epidemiological analysis: A hierarchical approach
86. Reductions in high-risk drug use behaviours among participants in the Baltimore needle-exchange program
87. A tale of two countries: Attempts to control HIV in Australia and the United States
88. Contextually specific effects and other generalizations of the hierarchical linear model for comparative analysis